Novartis AG
NOVNEE
Company Profile
Business description
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Contact
Lichtstrasse 35
Basel4056
CHET: +41 613241111
E: investor.relations@novartis.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
75,883
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,704.40 | 143.20 | -1.82% |
| CAC 40 | 7,104.35 | 177.23 | 2.56% |
| DAX 40 | 20,247.86 | 458.24 | 2.32% |
| Dow JONES (US) | 37,822.40 | 2,723.53 | -6.72% |
| FTSE 100 | 7,920.91 | 134.07 | -1.66% |
| HKSE | 20,127.68 | 2,722.13 | -11.91% |
| NASDAQ | 15,603.26 | 947.34 | -5.72% |
| Nikkei 225 | 33,012.58 | 768.00 | -2.27% |
| NZX 50 Index | 11,891.44 | 333.84 | -2.73% |
| S&P 500 | 5,041.94 | 20.31 | -0.40% |
| S&P/ASX 200 | 7,510.00 | 157.80 | -2.06% |
| SSE Composite Index | 3,145.55 | 48.97 | 1.58% |